BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30305534)

  • 1. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia].
    Shiba N
    Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current diagnosis and treatment for pediatric acute myeloid leukemia].
    Shiba N
    Rinsho Ketsueki; 2017; 58(4):389-399. PubMed ID: 28484171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
    Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
    Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutational Profiling of Pediatric Myeloid Leukemia Subtypes without Clinically Significant Chromosomal Aberrations].
    Ghukasyan LG; Krasnov GS; Muravenko OV; Baidun LV; Ibragimova SZ; Nasedkina TV
    Mol Biol (Mosk); 2019; 53(3):402-410. PubMed ID: 31184605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive molecular understanding of pediatric acute myeloid leukemia.
    Shiba N
    Int J Hematol; 2023 Feb; 117(2):173-181. PubMed ID: 36653696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance.
    Zhu YM; Wang PP; Huang JY; Chen YS; Chen B; Dai YJ; Yan H; Hu Y; Cheng WY; Ma TT; Chen SJ; Shen Y
    J Transl Med; 2017 Aug; 15(1):178. PubMed ID: 28830460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [AML treatment strategy based on cytogenetic abnormalities and somatic mutations].
    Imai Y
    Rinsho Ketsueki; 2015 Oct; 56(10):1932-41. PubMed ID: 26458431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
    Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
    Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
    Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
    Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F
    Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
    Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
    Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic abnormalities in AML].
    Nakajima H
    Rinsho Ketsueki; 2019; 60(6):584-593. PubMed ID: 31281149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
    Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
    Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene mutations in acute myeloid leukemia].
    Yamaguchi H
    Rinsho Ketsueki; 2016; 57(12):2535-2542. PubMed ID: 28090023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
    Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
    Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
    de Noronha TR; Mitne-Neto M; Chauffaille ML
    J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.
    Bolouri H; Farrar JE; Triche T; Ries RE; Lim EL; Alonzo TA; Ma Y; Moore R; Mungall AJ; Marra MA; Zhang J; Ma X; Liu Y; Liu Y; Auvil JMG; Davidsen TM; Gesuwan P; Hermida LC; Salhia B; Capone S; Ramsingh G; Zwaan CM; Noort S; Piccolo SR; Kolb EA; Gamis AS; Smith MA; Gerhard DS; Meshinchi S
    Nat Med; 2018 Jan; 24(1):103-112. PubMed ID: 29227476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.
    Obulkasim A; Katsman-Kuipers JE; Verboon L; Sanders M; Touw I; Jongen-Lavrencic M; Pieters R; Klusmann JH; Michel Zwaan C; van den Heuvel-Eibrink MM; Fornerod M
    Oncotarget; 2017 May; 8(20):33078-33085. PubMed ID: 28380436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.